The suppressive effects of extracellular regucalcin on liver cancer cell proliferation are mediated through different signaling pathways in vitro, including signaling pathways linked to NF-κB, intracellular calcium, MAPK, protein kinase C, PI3 kinase/Akt, transcription, and nuclear function. Here, AKT1 is linked to liver cancer.